These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11470343)

  • 1. Comorbid disruptive behavior disorder symptoms and their relationship to adolescent alcohol use disorders.
    Moss HB; Lynch KG
    Drug Alcohol Depend; 2001 Sep; 64(1):75-83. PubMed ID: 11470343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comorbidity of disruptive behavioral disorders and attention-deficit hyperactivity disorder--indicator of severity in problematic behavior?
    Nordström T; Ebeling H; Hurtig T; Rodriguez A; Savolainen J; Moilanen I; Taanila A
    Nord J Psychiatry; 2013 Aug; 67(4):240-8. PubMed ID: 23126481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparing the comorbidity of attention-deficit/hyperactivity disorder in childhood and adolescence].
    Keresztény A; Dallos G; Miklósi M; Róka A; Gádoros J; Balázs J
    Psychiatr Hung; 2012; 27(3):165-73. PubMed ID: 22781541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cathechol-O-methyltransferase Val(158)Met polymorphism is associated with disruptive behavior disorders among children and adolescents with ADHD.
    Salatino-Oliveira A; Genro JP; Guimarães AP; Chazan R; Zeni C; Schmitz M; Polanczyk G; Roman T; Rohde LA; Hutz MH
    J Neural Transm (Vienna); 2012 Jun; 119(6):729-33. PubMed ID: 22270685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognitive function in attention-deficit-hyperactivity disorder with and without comorbid disruptive behaviour disorders.
    Barnett R; Maruff P; Vance A
    Aust N Z J Psychiatry; 2009 Aug; 43(8):722-30. PubMed ID: 19629793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emotional lability in children and adolescents with attention deficit/hyperactivity disorder (ADHD): clinical correlates and familial prevalence.
    Sobanski E; Banaschewski T; Asherson P; Buitelaar J; Chen W; Franke B; Holtmann M; Krumm B; Sergeant J; Sonuga-Barke E; Stringaris A; Taylor E; Anney R; Ebstein RP; Gill M; Miranda A; Mulas F; Oades RD; Roeyers H; Rothenberger A; Steinhausen HC; Faraone SV
    J Child Psychol Psychiatry; 2010 Aug; 51(8):915-23. PubMed ID: 20132417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risperidone in comorbid ADHD and ODD/CD.
    Kewley GD
    J Am Acad Child Adolesc Psychiatry; 1999 Nov; 38(11):1327-8. PubMed ID: 10560215
    [No Abstract]   [Full Text] [Related]  

  • 8. The family psychosocial characteristics of children with attention-deficit hyperactivity disorder with or without oppositional or conduct problems in Japan.
    Satake H; Yamashita H; Yoshida K
    Child Psychiatry Hum Dev; 2004; 34(3):219-35. PubMed ID: 14767179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the relations among gender, disinhibition, and disruptive behavior in adolescents.
    Hartung CM; Milich R; Lynam DR; Martin CA
    J Abnorm Psychol; 2002 Nov; 111(4):659-64. PubMed ID: 12428779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Disruptive Behavior Disorders on Academic Performance and School Functions of Youths with Attention-Deficit/Hyperactivity Disorder.
    Liu CY; Huang WL; Kao WC; Gau SS
    Child Psychiatry Hum Dev; 2017 Dec; 48(6):870-880. PubMed ID: 28168530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychiatric problems associated with subthreshold ADHD and disruptive behaviour diagnoses in teenagers.
    Malmberg K; Edbom T; Wargelius HL; Larsson JO
    Acta Paediatr; 2011 Nov; 100(11):1468-75. PubMed ID: 21609359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Executive functioning characteristics associated with ADHD comorbidity in adolescents with disruptive behavior disorders.
    Hummer TA; Kronenberger WG; Wang Y; Dunn DW; Mosier KM; Kalnin AJ; Mathews VP
    J Abnorm Child Psychol; 2011 Jan; 39(1):11-9. PubMed ID: 20690008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of conduct disorder in the association between ADHD and alcohol use (disorder). Results from the Netherlands Mental Health Survey and Incidence Study-2.
    Tuithof M; ten Have M; van den Brink W; Vollebergh W; de Graaf R
    Drug Alcohol Depend; 2012 Jun; 123(1-3):115-21. PubMed ID: 22118715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long-term longitudinal course of oppositional defiant disorder and conduct disorder in ADHD boys: findings from a controlled 10-year prospective longitudinal follow-up study.
    Biederman J; Petty CR; Dolan C; Hughes S; Mick E; Monuteaux MC; Faraone SV
    Psychol Med; 2008 Jul; 38(7):1027-36. PubMed ID: 18205967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of comorbidity on the executive function of patients with attention deficit hyperactivity disorder (review)].
    Qian Y; Wang YF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 39(3):329-32. PubMed ID: 17572794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Findings on disruptive behavior disorders from the first decade of the Developmental Trends Study.
    Loeber R; Green SM; Lahey BB; Frick PJ; McBurnett K
    Clin Child Fam Psychol Rev; 2000 Mar; 3(1):37-60. PubMed ID: 11228766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motor abilities of adolescents with a disruptive behavior disorder: The role of comorbidity with ADHD.
    Van Damme T; Sabbe B; van West D; Simons J
    Res Dev Disabil; 2015 May; 40():1-10. PubMed ID: 25697736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atomoxetine versus placebo in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: a double-blind, randomized, multicenter trial in Germany.
    Dittmann RW; Schacht A; Helsberg K; Schneider-Fresenius C; Lehmann M; Lehmkuhl G; Wehmeier PM
    J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):97-110. PubMed ID: 21488751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Developmental Psychopathology Perspective on ADHD and Comorbid Conditions: The Role of Emotion Regulation.
    Steinberg EA; Drabick DA
    Child Psychiatry Hum Dev; 2015 Dec; 46(6):951-66. PubMed ID: 25662998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.